TerminatedNot Applicable

Hyperglycemia in Surgical Infections

Stopped: Difficulty in enrolling eligible patients

United States5 participantsStarted 2009-08

Plain-language summary

The primary purpose of this study is to evaluate two glycemic control regimens on clinical outcome in patients with necrotizing soft tissue infections. Secondary aim is to evaluate the inflammatory and immune responses to the glycemic control regimens.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients will be enrolled at one of the following centers: the LBJ General Hospital (UT-Houston), the Ben Taub General Hospital (Baylor Houston), The Methodist Hospital (Texas Medical Center), or the University of Texas Health Science Center at San Antonio and the Brooke Army Medical Center. * We will attempt to enroll all eligible patients with a diagnosis of a necrotizing soft tissue infection (NSTI), including Fournier's gangrene, confirmed in the operating room regardless of age, ethnicity or gender. Exclusion Criteria: * Pregnant patients

What they're measuring

Infectious Morbidity

Timeframe: Duration of hospital stay, an average of 2 weeks

Composite Outcome (Favorable Outcome Defined as Discharge Home, Without an Amputation, in Less Than the Median Hospital Stay for Survivors)

Timeframe: Duration of hospital stay

Trial details

NCT IDNCT00353275

SponsorThe University of Texas Health Science Center, Houston

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-07

Results submitted2014-02-19

View on ClinicalTrials.gov More Necrotizing Fasciitis trials